The search for biomarkers in Parkinson’s disease: a critical review

CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases

(2008) Jing Zhang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease

(2008) W. R. Wayne Martin et al.   ANNALS OF NEUROLOGY

RNA biomarkers of Parkinson’s disease: developing tools for novel therapies

(2008) Gerrit Hennecke et al.   Biomarkers in Medicine

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

(2008) M. Bogdanov et al.   BRAIN

Diagnostic Value of 123I-Ioflupane and 123I-Iodobenzamide SPECT Scans in 248 Patients with Parkinsonian Syndromes

(2008) Annemarie M.M. Vlaar et al.   EUROPEAN NEUROLOGY

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Metabolomic analysis of urine and serum in Parkinson’s disease

(2008) Andrew W. Michell et al.   Metabolomics

Mitochondrial function in Parkinson’s disease cybrids containing an nt2 neuron-like nuclear background

(2008) A. Raquel F. Esteves et al.   MITOCHONDRION

Early, untreated Parkinson's disease patients show reaction time variability

(2008) Richard M. Camicioli et al.   NEUROSCIENCE LETTERS

Technology Insight: imaging neurodegeneration in Parkinson's disease

(2008) David J Brooks   Nature clinical practice. Neurology

Myocardial123metaiodobenzylguanidine uptake in genetic Parkinson's disease

(2007) Aldo Quattrone et al.   MOVEMENT DISORDERS